Plazza raises $15m to grow rapid medicine delivery from 2 to 20 Bengaluru stores

Accel, Elevation Capital and Nexus Venture Partners led the funding round for Plazza, which plans to add Bengaluru stores, strengthen AI-led inventory and prepare for new-city launches. The startup is targeting a $10m annual run rate by December.

— Source publishedTue, 21 Jul, 2026, 18:09 IST·First seen Tue, 21 Jul, 2026, 18:12 IST·Source Outlook Business

What happened

Bengaluru rapid medicine-delivery startup Plazza raised $15 million to expand stores, strengthen AI-led inventory and prepare city launches. It plans to grow

Key facts

  • $15 million funding round
  • $45-50 million post-money valuation reported in April
  • $1.4 million previous funding round in September 2025
  • 2 current Bengaluru stores
  • 10 stores within a couple of months
  • around 20 stores by year-end
  • 3,000 stores targeted over the next 3-4 years
  • 35,000 medicines/SKUs per store
  • roughly 5,000 SKUs at a typical neighbourhood pharmacy
  • about 20,000 monthly orders
  • 80-90% of volume from chronic-illness patients
  • $1.5 million annual run rate last month
  • $10 million annual run-rate target by December

Why this matters

Plazza’s funded Bengaluru expansion and planned new-city launches make it a growing strategic target or partner for pharmacy chains, health platforms and last-mile delivery players seeking rapid-medicine capabilities.

What to watch

  • Monthly store-opening pace versus the target of about 20 Bengaluru locations by year-end.
  • Evidence of delivery-time reliability, fill rates, medicine stock-outs and inventory-expiry levels.
  • Progress toward the stated $10m annualized revenue run rate by December.
  • Customer acquisition cost, repeat purchase rates and contribution margin after delivery incentives.
  • Competitive responses from quick-commerce platforms, e-pharmacies and neighborhood pharmacy chains.
  • Regulatory developments affecting online prescription fulfillment, pharmacy licensing and medicine delivery operations.
  • Signs of a follow-on raise, especially if expansion begins before Bengaluru unit economics mature.
  • Open Bengaluru stores in dense residential and hospital-adjacent catchments before entering a second city.
  • Use funding to build demand forecasting, substitution workflows and expiry management for medicine-heavy inventory.
  • Prioritize chronic-care refills, diagnostics, wellness and OTC bundles to raise repeat frequency and basket size.
  • Lock in supply terms with distributors, brands and licensed pharmacy partners to protect availability and gross margin.
  • Test new-city launches only after demonstrating stable store-level contribution margins and repeat-order cohorts in Bengaluru.